• Product nameAnti-Als2 antibody
    See all Als2 primary antibodies
  • Description
    Rabbit polyclonal to Als2
  • Tested applicationsSuitable for: WBmore details
  • Species reactivity
    Reacts with: Human
    Predicted to work with: Mouse, Rat, Rabbit, Horse, Chicken, Guinea pig, Cow, Cat, Dog, Pig
  • Immunogen

    Synthetic peptide corresponding to a region within internal sequence amino acids 1007-1056 (ALRGMSDLPP YGSGSSVQRQ EPPISRSAKY TFYKDPRLKD ATYDGRWLSG) of Human Als2 (NP_065970).

  • Positive control
    • HepG2 cell lysate



Our Abpromise guarantee covers the use of ab104714 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB Use a concentration of 1 µg/ml. Predicted molecular weight: 184 kDa. Good results were obtained when blocked with 5% non-fat dry milk in 0.05% PBS-T.


  • FunctionMay act as a GTPase regulator. Controls survival and growth of spinal motoneurons.
  • Involvement in diseaseDefects in ALS2 are the cause of amyotrophic lateral sclerosis type 2 (ALS2) [MIM:205100]. ALS2 is a familial form of amyotrophic lateral sclerosis, a neurodegenerative disorder affecting upper and lower motor neurons and resulting in fatal paralysis. Sensory abnormalities are absent. Death usually occurs within 2 to 5 years. The etiology of amyotrophic lateral sclerosis is likely to be multifactorial, involving both genetic and environmental factors. The disease is inherited in 5-10% of cases leading to familial forms.
    Defects in ALS2 are the cause of juvenile primary lateral sclerosis (JPLS) [MIM:606353]. JPLS is a neurodegenerative disorder which is closely related to but clinically distinct from amyotrophic lateral sclerosis. It is a progressive paralytic disorder which results from dysfunction of the upper motor neurons of the motor cortex while the lower neurons are unaffected.
    Defects in ALS2 are the cause of infantile-onset ascending spastic paralysis (IAHSP) [MIM:607225]. IAHSP is characterized by progressive spasticity and weakness of limbs.
  • Sequence similaritiesContains 1 DH (DBL-homology) domain.
    Contains 8 MORN repeats.
    Contains 1 PH domain.
    Contains 5 RCC1 repeats.
    Contains 1 VPS9 domain.
  • Post-translational
    Phosphorylated upon DNA damage, probably by ATM or ATR.
  • Information by UniProt
  • Database links
  • Alternative names
    • ALS 2 antibody
    • ALS2 antibody
    • ALS2_HUMAN antibody
    • ALS2CR6 antibody
    • Alsin antibody
    • ALSJ antibody
    • Amyotrophic lateral sclerosis 2 (juvenile) antibody
    • Amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 6 antibody
    • Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 6 protein antibody
    • Amyotrophic lateral sclerosis 2 protein antibody
    • Amyotrophic lateral sclerosis protein 2 antibody
    • FLJ31851 antibody
    • IAHSP antibody
    • KIAA1563 antibody
    • MGC87187 antibody
    • PLSJ antibody
    see all

Anti-Als2 antibody images

  • Anti-Als2 antibody (ab104714) at 1 µg/ml + HepG2 cell lysate at 10 µg

    Predicted band size : 184 kDa

References for Anti-Als2 antibody (ab104714)

ab104714 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab104714.
Please use the links above to contact us or submit feedback about this product.